Australia became the first country to legalize MDMA and psilocybin for psychiatric treatment in 2023—a stunning victory achieved by two entrepreneurial outsiders who read a Michael Pollan article, took psychedelics in the Netherlands, and spent eight years building a grassroots movement, training clinicians, recruiting world-class advisors, and relentlessly navigating regulatory rejection to prove these medicines could save lives abandoned by conventional psychiatry. Tania and Peter de Jong launched Mind Medicine Australia with no background in psychedelics or research, relying instead on persistence, network-building, and strategic recruitment of world-leading scientists like David Nutt and Rick Doblin to overcome regulatory skepticism.